NEW YORK (GenomeWeb) –Lucigen said today that it has signed a global agreement with Illumina for Lucigen to be the sole distributor of Epicentre Technologies' genomics kits, enzymes, and ancillary reagents.

Products covered by the new agreement are in addition to select Epicentre products that were licensed and transferred to Lucigen for manufacture and distribution in December, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.